Diseases, Conditions, Syndromes

Poll: US trust in COVID-19 information down

Americans have lost trust across the board in the people and institutions informing them about the coronavirus since the beginning of the pandemic, according to a new poll from The Associated Press-NORC Center for Public ...

Diseases, Conditions, Syndromes

CDC changes, then retracts, web posting on how virus spreads

The top U.S. public health agency stirred confusion by posting—and then taking down—an apparent change in its position on how easily the coronavirus can spread from person to person through the air.

Diseases, Conditions, Syndromes

Major COVID-19 vaccine trial resumes in UK after safety review

Pharma giant AstraZeneca and Oxford University on Saturday said they had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.

Diseases, Conditions, Syndromes

WHO tempers quick vaccine hopes

The World Health Organization says it does not expect widespread immunisation against Covid-19 until mid-2021, despite growing expectations in the United States, the worst-hit nation, that a vaccine could be released within ...

Diseases, Conditions, Syndromes

A vaccine before the US election? Depends on science—or politics

A COVID-19 vaccine by election day in the US? Experts worry that, facing an uphill battle for reelection, President Donald Trump could press for one to be approved before the November 3 vote, but also before tests prove it ...

Vaccination

Pharma chiefs vow no 'cut corners' in vaccine race

Pharmaceutical company executives insisted Thursday they would not try to bring Covid-19 vaccines or treatments to market that did not meet rigorous safety and efficiency standards.

page 1 from 2